PT2686002T - Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápida - Google Patents
Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápidaInfo
- Publication number
- PT2686002T PT2686002T PT127194876T PT12719487T PT2686002T PT 2686002 T PT2686002 T PT 2686002T PT 127194876 T PT127194876 T PT 127194876T PT 12719487 T PT12719487 T PT 12719487T PT 2686002 T PT2686002 T PT 2686002T
- Authority
- PT
- Portugal
- Prior art keywords
- titulation
- rapid
- symptoms associated
- intramuscular administration
- reducing fluid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161452807P | 2011-03-15 | 2011-03-15 | |
| US201161476930P | 2011-04-19 | 2011-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2686002T true PT2686002T (pt) | 2018-04-23 |
Family
ID=46045072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT127194876T PT2686002T (pt) | 2011-03-15 | 2012-03-15 | Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápida |
Country Status (25)
| Country | Link |
|---|---|
| US (6) | US9198955B2 (enExample) |
| EP (1) | EP2686002B1 (enExample) |
| JP (2) | JP6279905B2 (enExample) |
| KR (1) | KR102050339B1 (enExample) |
| CN (1) | CN103702680A (enExample) |
| AU (1) | AU2012229104B2 (enExample) |
| BR (1) | BR112013023609A8 (enExample) |
| CA (1) | CA2846786C (enExample) |
| CY (1) | CY1120176T1 (enExample) |
| DK (1) | DK2686002T3 (enExample) |
| EA (1) | EA028448B1 (enExample) |
| ES (1) | ES2666850T3 (enExample) |
| HR (1) | HRP20180621T1 (enExample) |
| HU (1) | HUE036931T2 (enExample) |
| IL (1) | IL228425A (enExample) |
| LT (1) | LT2686002T (enExample) |
| MX (1) | MX359947B (enExample) |
| PL (1) | PL2686002T3 (enExample) |
| PT (1) | PT2686002T (enExample) |
| RS (1) | RS57175B1 (enExample) |
| SG (1) | SG193446A1 (enExample) |
| SI (1) | SI2686002T1 (enExample) |
| SM (1) | SMT201800221T1 (enExample) |
| WO (1) | WO2012125809A1 (enExample) |
| ZA (1) | ZA201306933B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2846786C (en) * | 2011-03-15 | 2022-05-17 | Biogen Idec Inc. | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
| EP3092305B1 (en) | 2014-01-09 | 2023-08-02 | Kyushu University, National University Corporation | Method of producing microglial cells |
| WO2018056584A1 (ko) | 2016-09-21 | 2018-03-29 | 삼성전자 주식회사 | 피부 상태 측정 방법 및 이를 위한 전자 장치 |
| WO2022069250A1 (en) * | 2020-09-30 | 2022-04-07 | Koninklijke Philips N.V. | Methods and systems for performing dose titration |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456748A (en) | 1981-02-23 | 1984-06-26 | Genentech, Inc. | Hybrid human leukocyte interferons |
| WO1982002715A1 (fr) | 1981-02-04 | 1982-08-19 | Sugano Haruo | Gene d'interferon (beta)humain |
| US4695543A (en) | 1982-03-23 | 1987-09-22 | Bristol-Myers Company | Alpha Interferon GX-1 |
| CA1302320C (en) | 1984-06-11 | 1992-06-02 | Hideo Niwa | Expression of human cromosomal interferon-_ in animal cells |
| US5231176A (en) | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons |
| FI90990C (fi) | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
| ATE78262T1 (de) | 1985-06-11 | 1992-08-15 | Ciba Geigy Ag | Hybrid-interferone. |
| US5641656A (en) | 1993-10-22 | 1997-06-24 | University Of Connecticut | Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them |
| DE69729880T3 (de) * | 1996-12-24 | 2012-05-10 | Biogen Idec Ma Inc. | Stabile flüssige interferon-zubereitungen |
| JP2001104482A (ja) * | 1999-10-07 | 2001-04-17 | Terumo Corp | ２室型プレフィルドシリンジ |
| US8932265B2 (en) * | 2003-01-30 | 2015-01-13 | Becton, Dickinson And Company | Holder with safety shield for a drug delivery device |
| US7731948B2 (en) * | 2004-06-01 | 2010-06-08 | Ares Trading S.A. | Stabilized interferon liquid formulations |
| US20060089593A1 (en) * | 2004-10-26 | 2006-04-27 | Sergio Landau | Needle-free injection device for individual users |
| EP1923085A1 (en) * | 2006-11-17 | 2008-05-21 | Sanofi-Aventis Deutschland GmbH | Dosing and drive mechanism for drug delivery device |
| US8071544B2 (en) * | 2006-12-18 | 2011-12-06 | Althea Technologies, Inc. | Crystallized recombinant human growth factor formulations |
| US9044378B2 (en) * | 2007-05-31 | 2015-06-02 | Safety Syringes, Inc. | Anti-needle stick safety device or system for use with drugs requiring reconstitution |
| JP5549048B2 (ja) * | 2007-08-16 | 2014-07-16 | 味の素株式会社 | 薬剤バイアルとプレフィルドシリンジの接続構造 |
| MX2011013722A (es) * | 2009-06-18 | 2012-05-08 | Wyeth Llc | Formulaciones liofilizadas para inmunofarmaceuticos modulares pequeños. |
| CA2846786C (en) * | 2011-03-15 | 2022-05-17 | Biogen Idec Inc. | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
-
2012
- 2012-03-15 CA CA2846786A patent/CA2846786C/en active Active
- 2012-03-15 HU HUE12719487A patent/HUE036931T2/hu unknown
- 2012-03-15 WO PCT/US2012/029201 patent/WO2012125809A1/en not_active Ceased
- 2012-03-15 HR HRP20180621TT patent/HRP20180621T1/hr unknown
- 2012-03-15 KR KR1020137027053A patent/KR102050339B1/ko active Active
- 2012-03-15 US US13/421,197 patent/US9198955B2/en active Active
- 2012-03-15 ES ES12719487.6T patent/ES2666850T3/es active Active
- 2012-03-15 RS RS20180455A patent/RS57175B1/sr unknown
- 2012-03-15 DK DK12719487.6T patent/DK2686002T3/en active
- 2012-03-15 JP JP2013558168A patent/JP6279905B2/ja active Active
- 2012-03-15 CN CN201280019863.2A patent/CN103702680A/zh active Pending
- 2012-03-15 PL PL12719487T patent/PL2686002T3/pl unknown
- 2012-03-15 SM SM20180221T patent/SMT201800221T1/it unknown
- 2012-03-15 AU AU2012229104A patent/AU2012229104B2/en active Active
- 2012-03-15 SG SG2013069018A patent/SG193446A1/en unknown
- 2012-03-15 PT PT127194876T patent/PT2686002T/pt unknown
- 2012-03-15 LT LTEP12719487.6T patent/LT2686002T/lt unknown
- 2012-03-15 EP EP12719487.6A patent/EP2686002B1/en active Active
- 2012-03-15 SI SI201231281T patent/SI2686002T1/en unknown
- 2012-03-15 BR BR112013023609A patent/BR112013023609A8/pt not_active Application Discontinuation
- 2012-03-15 MX MX2013010507A patent/MX359947B/es active IP Right Grant
- 2012-03-15 EA EA201301024A patent/EA028448B1/ru unknown
-
2013
- 2013-09-12 ZA ZA2013/06933A patent/ZA201306933B/en unknown
- 2013-09-12 IL IL228425A patent/IL228425A/en active IP Right Grant
-
2015
- 2015-11-09 US US14/936,228 patent/US20160101157A1/en not_active Abandoned
-
2017
- 2017-09-05 JP JP2017170640A patent/JP6522069B2/ja active Active
- 2017-09-05 US US15/695,587 patent/US10500254B2/en active Active
-
2018
- 2018-04-23 CY CY20181100424T patent/CY1120176T1/el unknown
-
2019
- 2019-10-22 US US16/660,038 patent/US20200046804A1/en not_active Abandoned
-
2022
- 2022-05-27 US US17/827,282 patent/US20220280610A1/en not_active Abandoned
-
2025
- 2025-05-05 US US19/198,871 patent/US20250276042A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2782630T3 (da) | Medikamentleveringssystem med en forsinkelsesmekanisme | |
| DK3329965T3 (da) | Doseringsregime for anti-alpha4beta7-antistof | |
| DK2701773T3 (da) | Dosisstyredele til injektionssprøjte | |
| BR112012009778A2 (pt) | regime de dosagem para administrar um anticorpo biespecífico de cd19xcd3 | |
| BR112013018900A2 (pt) | conjuntos para uma estrutura | |
| PT2672973T (pt) | Regime de administração para nitrocatecóis | |
| BR112014016062A2 (pt) | método para fabricação de um artigo limpável, artigo limpável e método para utilizar um artigo limpável | |
| ES2746233T8 (es) | Vacunas individualizadas para el cáncer | |
| BR112014004960A2 (pt) | mecanismo de inserção para uma bomba de administração de fármaco | |
| DK2665503T3 (da) | Medikamenttilførselsanordning | |
| BR112014003798A2 (pt) | método para fabricar um composto, e, composto | |
| EP2667915A4 (en) | INJEKTOR | |
| SMT201500209B (it) | Forme di dosaggio farmaceutiche a rilascio controllato | |
| BR112013029138A2 (pt) | procedimento para assinatura digital múltipla | |
| ZA201403288B (en) | Valve for administration of a plurality of drug fluids | |
| BR112013014546A2 (pt) | dispositivo e método para administração de um dispositivo vascular | |
| BR112014008603A2 (pt) | tablete, e, método para produzir um tablete | |
| PT2772261T (pt) | Adsorvente administrado oralmente | |
| IL231622B (en) | Pharmaceutical composition for treatment of cachexia | |
| BR112013019917A2 (pt) | dispositivo para uma válvula | |
| BR112013032690A2 (pt) | método para produzir um composto, composto, e, uso do mesmo | |
| HUE039907T2 (hu) | Gyógyszer-szállító technológia | |
| BR112014015469A8 (pt) | método para controlar uma disposição de bomba | |
| BR112014005307A2 (pt) | artigo resistente balístico, método para produzir um artigo resistente balístico | |
| BR112014002631A2 (pt) | soluções antiinflamatórias estáveis para injeção |